Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

High blood pressure, also called hypertension, affects over 1.5 billion people around the world. It increases the risk of ...

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

Hypertension affects one in three adults globally and is the leading modifiable risk factor for cardiovascular disease.

Expanded screening using the Vaidya & Carey algorithm significantly improved primary aldosteronism detection in patients with ...

A large number of hypertension patients may unknowingly suffer from primary aldosteronism (PA) — a common but underdiagnosed ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

b Due to production of non-aldosterone mineralocorticoids. c Acquired forms due to DOC-producing tumors. d Due to increased activity of MCRs. e Acquired forms due to either licorice ingestion or ...